FDA Approval of Eteplirsen for Muscular Dystrophy

Authors:

Abstract
To the Editor Drs Kesselheim and Avorn raised concerns about the approval by the US Food and Drug Administration (FDA) of eteplirsen to treat Duchenne muscular

This publication has 1 reference indexed in Scilit: